Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
59,490,714
-
Share change
-
+1,621,603
-
Total reported value
-
$3,129,967,197
-
Put/Call ratio
-
118%
-
Price per share
-
$52.60
-
Number of holders
-
218
-
Value change
-
+$84,209,548
-
Number of buys
-
136
-
Number of sells
-
72
Institutional Holders of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) as of Q2 2019
As of 30 Jun 2019,
GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) was held by
218 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,490,714 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, BANK OF AMERICA CORP /DE/, JANUS HENDERSON GROUP PLC, STATE STREET CORP, and FRANKLIN RESOURCES INC.
This page lists
218
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.